Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. An increasing number of companion animal ownership
4.1.1.2. Advances in animal health medicines and vaccines.
4.1.2. Restraints:
4.1.2.1. Sales of antimicrobials for animals are decreasing.
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1 Porter’s Five Forces Analysis
5.2 Supply Chain Analysis
5.3 Pricing Analysis
5.4 Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Anti-Infectives
7.2.1. Introduction
7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
7.3. Vaccines
7.4. Medicinal Feed Additives
7.5. Parasiticides
7.6. Diagnostics
7.7. Others
8. By Animals
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animals
8.1.2. Market Attractiveness Index, By Animals
8.2. Cats
8.2.1. Introduction
8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
8.3. Dogs
8.4. Equine
8.5. Others
9. By Country
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Country
9.1.2. Market Attractiveness Index, By Country
9.2. Germany
9.2.1. Introduction
9.2.2. Key Country-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animals
9.3. U.K.
9.3.1. Introduction
9.3.2. Key Country-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animals
9.4. France
9.4.1. Introduction
9.4.2. Key Country-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animals
9.5. Italy
9.5.1. Introduction
9.5.2. Key Country-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animals
9.6. Spain
9.6.1. Introduction
9.6.2. Key Country-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animals
9.7. Rest of Europe
9.7.1. Introduction
9.7.2. Key Country-Specific Dynamics
9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animals
10. Competitive Landscape
10.1. Key Developments and Strategies
10.2. Products Benchmarking
10.3. List of Key Companies to Watch
11. Company Profiles
11.1. Zoetis
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Boehringer Ingelheim
11.3. Ceva Sante Animale
11.4. Elanco
11.5. Merck Animal Health
11.6. IDEXX Laboratories
11.7. VetPharma
11.8. Dechra Pharmaceuticals
11.9. Neogen Corporation
11.10. Inovet
LIST NOT EXHAUSTIVE
12. Europe Companion Animal Health Market – DataM
12.1. Appendix
12.2. About Us and Application
12.3. Contact Us